生长分化因子15和细胞因子对老年冠心病合并衰弱病人的诊断价值

doi:10.3969/j.issn.1003-9198.2023.10.008

摘要/Abstract

摘要： 目的探讨生长分化因子15(GDF15)和细胞因子对老年CHD合并衰弱病人的诊断价值。方法选取徐州医科大学附属医院在2022年7～9月间收治的88例老年CHD病人为研究对象,根据Frail衰弱量表分为衰弱组(27例)和非衰弱组(61例)。比较2组间一般资料、血清GDF15水平、细胞因子水平;绘制ROC曲线,分析GDF15及细胞因子对老年CHD合并衰弱的诊断价值。结果衰弱组年龄、年龄修正查尔森共病指数(age-adjusted Charlson comorbidity index, ACCI)、IL-1β、IL-5、IL-6、IL-10、IFN-α、IFN-γ、TNF-α和GDF15水平均明显高于非衰弱组(P＜0.05)。ROC曲线分析显示,IFN-α、IFN-γ、GDF15联合诊断老年CHD病人合并衰弱的敏感度和特异度分别为85.19%和78.69%(AUC=0.868,95%CI:0.798～0.942),优于单项指标的诊断价值(P＜0.05)。结论 IFN-α、IFN-γ、GDF15单独或联合均可作为老年CHD病人合并衰弱的诊断指标,且联合诊断的效能更高。

关键词: 老年人, 冠心病, 衰弱, 生长分化因子15, 细胞因子, 诊断价值

Abstract: Objective To investigate the diagnostic value of growth differentiation factor 15 (GDF15) and cytokines in the elderly patients with coronary heart disease (CHD) complicated with frailty. Methods A total of 88 elderly CHD patients treated at the Affiliated Hospital of Xuzhou Medical University from July to September 2022 were enrolled in this study. According to the Frail scale, the patients were divided into the frailty group (27 cases) and the non-frailty group (61 cases). The general data, serum levels of GDF15 and cytokines of the two groups were detected and compared. The receiver operating characteristic(ROC)curve was used to analyze the diagnostic value of GDF15 and cytokines for frailty in the elderly patients with CHD. Results The age, age-adjusted Charlson comorbidity index (ACCI) and the levels of GDF15, interleukin-1β(IL-1β), IL-5, IL-6, IL-10, interferon-α(IFN-α), IFN-γ and tumor necrosis factor-α(TNF-α) in the frailty group were significantly higher than those in the non-frailty group (P＜0.05). The area under the ROC curve (AUC) showed that the combined diagnosis of IFN-α, IFN-γ and GDF15 for frailty in the elderly CHD patients was superior to the diagnostic value of each single indicator (P＜0.05). Conclusions IFN-α, IFN-γ and GDF15 can serve as diagnostic indicators for frailty in the elderly CHD patients, and the efficacy of the combination of three indicators is higher.

Key words: aged, coronary heart disease, frailty, growth differentiation facor 15, cytokines, diagnostic value

中图分类号:

R 541.4

杨雪, 甯春, 赵娟, 郝敬波, 杨荣礼. 生长分化因子15和细胞因子对老年冠心病合并衰弱病人的诊断价值[J]. 实用老年医学, 2023, 37(10): 1009-1013.

YANG Xue, NING Chun, ZHAO Juan, HAO Jing-bo, YANG Rong-li. Diagnostic value of growth differentiation factor 15 and cytokines in elderly patients with coronary heart disease complicated with frailty[J]. Practical Geriatrics, 2023, 37(10): 1009-1013.

参考文献

[1] QU J, ZHOU T, XUE M, et al. Relationship between medication literacy and frailty in elderly inpatients with coronary heart disease: a cross-sectional study in china[J]. Front Pharmacol, 2021, 12: 691983.
[2] QIN T, SHENG W, HU G. To analyze the influencing factors of senile coronary heart disease patients complicated with frailty syndrome[J]. J Healthc Eng, 2022, 2022: 7619438.
[3] SOYSAL P, ARIK F, SMITH L, et al. Inflammation, frailty and cardiovascular disease[J]. Adv Exp Med Biol, 2020, 1216: 55-64.
[4] UCHMANOWICZ I. Oxidative stress, frailty and cardiovascular diseases: current evidence[J]. Adv Exp Med Biol, 2020, 1216: 65-77.
[5] CARDOSO A L, FERNANDES A, AGUILAR-PIMENTEL J A, et al. Towards frailty biomarkers: candidates from genes and pathways regulated in aging and age-related diseases[J]. Ageing Res Rev, 2018, 47: 214-277.
[6] 中华医学会心血管病学分会介入心脏病学组, 中华医学会心血管病学分会动脉粥样硬化与冠心病学组, 中国医师协会心血管内科医师分会血栓防治专业委员会, 等. 稳定性冠心病诊断与治疗指南[J]. 中华心血管病杂志, 2018, 46(9): 680-694.
[7] WANG D, DAY E A, TOWNSEND L K, et al. GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease[J]. Nat Rev Endocrinol, 2021, 17(10): 592-607.
[8] ANGIONI D, LU W H, SOURDET S, et al. Biomarkers of age-related frailty and frailty related to diseases: an exploratory, cross-sectional analysis from the mapt study[J]. J Nutr Health Aging, 2022, 26(6): 545-551.
[9] AHMED D, ISNARD S, BERINI C, et al. Coping with stress: the mitokine GDF-15 as a biomarker of COVID-19 severity[J]. Front Immunol, 2022, 13: 820350.
[10] ARAUNA D, GARCíA F, RODRíGUEZ-MAñAS L, et al. Older adults with frailty syndrome present an altered platelet function and an increased level of circulating oxidative stress and mitochondrial dysfunction biomarker GDF-15[J]. Free Radic Biol Med, 2020, 149: 64-71.
[11] CONTE M, MARTUCCI M, MOSCONI G, et al. GDF15 plasma level is inversely associated with level of physical activity and correlates with markers of inflammation and muscle weakness[J]. Front Immunol, 2020, 11: 915.
[12] OBA K, ISHIKAWA J, TAMURA Y, et al. Serum growth differentiation factor 15 level is associated with muscle strength and lower extremity function in older patients with cardiometabolic disease[J]. Geriatr Gerontol Int, 2020, 20(10): 980-987.
[13] ASSADI A, ZAHABI A, HART R A. GDF15, an update of the physiological and pathological roles it plays: a review[J]. Pflugers Arch, 2020, 472(11): 1535-1546.
[14] MIR R, JHA C K, KHULLAR N, et al. The role of inflammatory and cytokine biomarkers in the pathogenesis of frailty syndrome[J]. Endocr Metab Immune Disord Drug Targets, 2022, 22(14): 1357-1366.
[15] MOHAMAD M, EBEID S, SHAWKY KHATER M, et al. Interferon-gamma-inducible guanosine triphosphate cyclohydrolase 1 (GTP-CH1) pathway is associated with frailty in egyptian elderly[J]. Rep Biochem Mol Biol, 2018, 7(1): 52-58.
[16] YANG Z X, MAO G X, ZHANG J, et al. IFN-γ induces senescence-like characteristics in mouse bone marrow mesenchymal stem cells[J]. Adv Clin Exp Med, 2017, 26(2): 201-206.
[17] XU Y, WANG M, CHEN D, et al. Inflammatory biomarkers in older adults with frailty: a systematic review and meta-analysis of cross-sectional studies[J]. Aging Clin Exp Res, 2022, 34(5): 971-987.
[18] FURTADO G E, UBA CHUPEL M, MINUZZI L, et al. Exploring the potential of salivary and blood immune biomarkers to elucidate physical frailty in institutionalized older women[J]. Exp Gerontol, 2020, 129: 110759.